Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
1.390
-0.200 (-12.58%)
At close: Apr 1, 2025, 4:00 PM
1.370
-0.020 (-1.44%)
After-hours: Apr 1, 2025, 4:07 PM EDT

Zentalis Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2018
Market Capitalization
1002161,0721,1493,8082,109
Upgrade
Market Cap Growth
-79.86%-79.86%-6.72%-69.82%80.54%-
Upgrade
Enterprise Value
-220-1326017753,4431,769
Upgrade
Last Close Price
1.593.0315.1520.1484.0651.94
Upgrade
PS Ratio
1.683.20----
Upgrade
PB Ratio
0.340.642.452.6510.456.33
Upgrade
P/TBV Ratio
0.640.642.472.6710.577.13
Upgrade
Debt / Equity Ratio
0.130.130.110.110.130.01
Upgrade
Asset Turnover
0.140.14----
Upgrade
Quick Ratio
7.137.136.967.727.7411.85
Upgrade
Current Ratio
7.327.327.167.987.9812.07
Upgrade
Return on Equity (ROE)
-42.83%-42.83%-67.09%-59.39%-47.60%-59.01%
Upgrade
Return on Assets (ROA)
-23.86%-23.86%-28.53%-28.59%-31.67%-32.77%
Upgrade
Return on Capital (ROIC)
-27.15%-27.15%-32.27%-31.86%-34.82%-36.70%
Upgrade
Earnings Yield
-152.99%-76.80%-27.25%-20.60%-4.17%-5.59%
Upgrade
FCF Yield
-157.82%-79.23%-19.44%-14.47%-4.21%-4.15%
Upgrade
Buyback Yield / Dilution
-8.67%-8.67%-23.75%-23.82%-51.84%-402.29%
Upgrade
Updated Mar 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q